SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-338561
Filing Date
2017-11-09
Accepted
2017-11-09 14:35:07
Documents
91
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d464245d10q.htm 10-Q 562756
2 EXHIBIT 31.1 d464245dex311.htm EX-31.1 6431
3 EXHIBIT 31.2 d464245dex312.htm EX-31.2 6417
4 EXHIBIT 32.1 d464245dex321.htm EX-32.1 6237
  Complete submission text file 0001193125-17-338561.txt   5174145

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rgen-20170930.xml EX-101.INS 821557
6 XBRL TAXONOMY EXTENSION SCHEMA rgen-20170930.xsd EX-101.SCH 55345
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgen-20170930_cal.xml EX-101.CAL 92249
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgen-20170930_def.xml EX-101.DEF 448453
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20170930_lab.xml EX-101.LAB 521432
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20170930_pre.xml EX-101.PRE 526316
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14656 | Film No.: 171190175
SIC: 2836 Biological Products, (No Diagnostic Substances)